Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,763,757
+$70,011 QoQ
Shares Held
17,635
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#360
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. NVS ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
This page
|
17,635 | $2,763,757 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,763,757 | 17,635 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,693,746 | 17,635 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,493,516 | 18,086 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,348,330 | 18,312 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,535,764 | 20,955 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,005,277 | 26,958 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,798,440 | 28,758 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,322,122 | 28,883 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,127,581 | 29,378 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,882,263 | 29,797 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,268,095 | 32,367 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,812,517 | 37,429 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,776,960 | 37,429 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,466,468 | 37,679 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,457,429 | 38,111 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,991,221 | 39,353 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,408,080 | 40,318 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,667,335 | 41,793 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,945,071 | 45,102 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $4,252,232 | 51,996 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,624,398 | 61,644 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $11,849,323 | 138,621 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $16,283,320 | 172,438 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $15,086,951 | 173,493 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $15,486,501 | 187,829 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||